Abstract:Hyperactivity in the LCN‐linked regions within short QPPs observed before motor impairment onset. DMLN QPP presents a progressive decrease in DMLN activity and occurrence along HD‐like phenotype development. Breakdown of the LCN DMLN state flux at motor onset leads to a subsequent absence of the LCN DMLN QPP at an advanced HD‐like stage. Background Huntington's disease (HD) is marked by irreversible loss of neuronal function for which currently no availability for disease‐modifying treatment exists. Advances in the understanding of disease progression can aid biomarker development, which in turn can accelerate therapeutic discovery. Methods We characterised the progression of altered dynamics of whole‐brain network states in the zQ175DN mouse model of HD using a dynamic functional connectivity (FC) approach to resting‐state fMRI and identified quasi‐periodic patterns (QPPs) of brain activity constituting the most prominent resting‐state networks. Results The occurrence of the normative QPPs, as observed in healthy controls, was reduced in the HD model as the phenotype progressed. This uncovered progressive cessation of synchronous brain activity with phenotypic progression, which is not observed with the conventional static FC approaches. To better understand the potential underlying cause of the observed changes in these brain states, we further assessed how mutant huntingtin (mHTT) protein deposition affects astrocytes and pericytes – one of the most important effectors of neurovascular coupling, along phenotypic progression. Increased cell‐type dependent mHTT deposition was observed at the age of onset of motor anomalies, in the caudate putamen, somatosensory and motor cortex, regions that are prominently involved in HD pathology as seen in humans. Conclusion Our findings provide meaningful insights into the development and progression of altered functional brain dynamics in this HD model and open new avenues in assessing the dynamics of whole brain states, through QPPs, in clinical HD research. Highlights Hyperactivity in the LCN‐linked regions within short QPPs observed before motor impairment onset. DMLN QPP presents a progressive decrease in DMLN activity and occurrence along HD‐like phenotype development. Breakdown of the LCN DMLN state flux at motor onset leads to a subsequent absence of the LCN DMLN QPP at an advanced HD‐like stage.

Developmental alterations of indirect-pathway medium spiny neurons in mouse models of Huntington's disease.

Corticostriatal Maldevelopment in the R6/2 Mouse Model of Juvenile Huntington Disease

Corticostriatal Maldevelopment in the R6/2 Mouse Model of Juvenile Huntington's Disease

Early alterations of motor learning and corticostriatal network activity in a Huntington's disease mouse model

Pathological Cell-Cell Interactions Are Necessary for Striatal Pathogenesis in a Conditional Mouse Model of Huntington's Disease.

Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system

Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington’s disease

Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease

Abnormal Outer and Inner Retina in a Mouse Model of Huntington’s Disease with Age

Pathological Cell-Cell Interactions Elicited by a Neuropathogenic Form of Mutant Huntingtin Contribute to Cortical Pathogenesis in HD Mice

Evolution of aberrant brain‐wide spatiotemporal dynamics of resting‐state networks in a Huntington's disease mouse model

Differential contribution of direct and indirect pathways from dorsolateral and dorsomedial striatum to motor symptoms in Huntington's disease mice

Dysregulation of protein SUMOylation networks in Huntington's disease R6/2 mouse striatum

Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice

Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease

Mutant HTT Does Not Affect Glial Development but Impairs Myelination in the Early Disease Stage

Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease

Impaired Ubiquitin–proteasome System Activity in the Synapses of Huntington's Disease Mice

Expression of Mutant Huntingtin in Mouse Brain Astrocytes Causes Age-Dependent Neurological Symptoms